Texas Yale Capital Corp. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Texas Yale Capital Corp. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$351,621
+31.9%
3,452
+30.7%
0.02%
+23.1%
Q2 2023$266,604
+8.7%
2,642
-0.9%
0.01%
+8.3%
Q1 2023$245,180
-29.7%
2,665
-30.7%
0.01%
-40.0%
Q4 2022$348,818
+19.5%
3,8450.0%0.02%
+5.3%
Q3 2022$292,000
-10.2%
3,8450.0%0.02%
-9.5%
Q2 2022$325,000
-3.6%
3,8450.0%0.02%
+16.7%
Q1 2022$337,000
+0.3%
3,8450.0%0.02%
+5.9%
Q4 2021$336,000
+7.0%
3,8450.0%0.02%
-5.6%
Q3 2021$314,000
-10.5%
3,8450.0%0.02%
-10.0%
Q2 2021$351,000
+6.7%
3,8450.0%0.02%
-4.8%
Q1 2021$329,000
-43.8%
3,845
-37.9%
0.02%
-46.2%
Q4 2020$585,000
+8.5%
6,1950.0%0.04%
-4.9%
Q3 2020$539,000
-0.4%
6,1950.0%0.04%
-6.8%
Q2 2020$541,000
+51.1%
6,195
+42.7%
0.04%
+25.7%
Q1 2020$358,000
-12.9%
4,3420.0%0.04%
+25.0%
Q4 2019$411,000
+9.0%
4,3420.0%0.03%
+3.7%
Q3 2019$377,000
-4.8%
4,3420.0%0.03%
-10.0%
Q2 2019$396,000
-52.5%
4,342
-50.0%
0.03%
-9.1%
Q1 2019$834,000
+123.6%
8,684
+100.0%
0.03%
-2.9%
Q4 2018$373,000
-0.3%
4,3420.0%0.03%
+13.3%
Q3 2018$374,000
+14.0%
4,3420.0%0.03%
+7.1%
Q2 2018$328,000
-6.6%
4,3420.0%0.03%
-6.7%
Q1 2018$351,000
-3.8%
4,3420.0%0.03%
-3.2%
Q4 2017$365,000
+2.5%
4,342
+4.7%
0.03%0.0%
Q3 2017$356,000
+2.9%
4,1470.0%0.03%
+3.3%
Q2 2017$346,000
+12.3%
4,1470.0%0.03%
+11.1%
Q1 2017$308,000
+2.0%
4,1470.0%0.03%
-6.9%
Q4 2016$302,000
-49.0%
4,147
-44.7%
0.03%
-49.1%
Q3 2016$592,000
-4.4%
7,4970.0%0.06%
-8.1%
Q2 2016$619,000
+73.4%
7,497
+52.1%
0.06%
+67.6%
Q1 2016$357,000
-15.8%
4,9280.0%0.04%
-9.8%
Q4 2015$424,000
-6.4%
4,9280.0%0.04%
-4.7%
Q3 2015$453,000
-6.6%
4,9280.0%0.04%
+7.5%
Q2 2015$485,000
-0.2%
4,9280.0%0.04%
+2.6%
Q1 2015$486,000
-46.3%
4,928
-49.5%
0.04%
-50.0%
Q4 2014$905,000
-48.5%
9,767
-47.7%
0.08%
-14.3%
Q3 2014$1,758,000
+331.9%
18,672
+315.2%
0.09%
+78.4%
Q2 2014$407,000
-46.7%
4,497
-50.0%
0.05%
-5.6%
Q1 2014$764,000
+111.6%
8,994
+100.0%
0.05%
-1.8%
Q4 2013$361,000
+4.6%
4,4970.0%0.06%
-5.2%
Q3 2013$345,0004,4970.06%
Other shareholders
NOVARTIS A G shareholders Q4 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders